Author

Alyson Bradbury

Institutions: Sheffield Children's NHS Foundation Trust, Sheffield Children's Hospital

Observed institutions: Royal Hallamshire Hospital, Whyteman’s Brae Hospital, Sheffield Children's NHS Foundation Trust, Sheffield Children's Hospital

OpenAlex ID: A5000410639

CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion

2012 · J.-M. Lee, E.M. Ramos, et al. · Neurology · 382

Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study

2017 · Davina J Hensman Moss, Antonio F Pardiñas, et al. · The Lancet Neurology · 310

Clinical manifestations of intermediate allele carriers in Huntington disease

2016 · Esther Cubo, María A. Ramos-Arroyo, et al. · Neurology · 53

Two families with sibling recurrence of the 17q21.31 microdeletion syndrome due to low-grade mosaicism

2012 · David A Koolen, Juliette Dupont, et al. · European Journal of Human Genetics · 48

Reduced Cancer Incidence in Huntington’s Disease: Analysis in the Registry Study

2018 · Paul McNulty, Richard Pilcher, et al. · Journal of Huntington s Disease · 35

Meaningful and Measurable Health Domains in Huntington’s Disease: Large-Scale Validation of the Huntington’s Disease Health-Related Quality of Life Questionnaire Across Severity Stages

2019 · Aileen K. Ho, Mike C. Horton, et al. · Value in Health · 9

G001 2023 UK national audit of predictive testing for Huntington’s disease

2024 · Nayana Lahiri, Lauren Limb, et al.

Works count: 7

Citation count: 837

H-index: 6

I10-index: 5